We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+44.49%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.35B
AUM Growth
+$376M
(+38%)
Cap. Flow
+$77.8M
Cap. Flow
% of AUM
5.75%
Top 10 Holdings %
Top 10 Hldgs %
52.62%
Holding
81
New
21
Increased
33
Reduced
5
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$26.6M |
| 2 |
Arrowhead Research
ARWR
|
+$26.5M |
| 3 |
Prothena Corp
PRTA
|
+$24.3M |
| 4 |
Halozyme
HALO
|
+$23.9M |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$19.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$134M |
| 2 |
AMRN
Amarin Corp
AMRN
|
+$9.41M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$9.22M |
| 4 |
KORU Medical Systems
KRMD
|
+$7.76M |
| 5 |
CareDx
CDNA
|
+$5.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.3% |
| 2 | Communication Services | 3.46% |
| 3 | Energy | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
AbbVie
ABBV
$443B
| $641K | 0.05% |
5,981
| – | – |
|
52
UnitedHealth
UNH
$376B
| $541K | 0.04% |
1,543
+851
| +123% | +$285K |
|
53
Becton Dickinson
BDX
$45.6B
| $416K | 0.03% |
+1,704
| New | +$397K |
|
54
Elevance Health
ELV
$81.5B
| $399K | 0.03% |
1,244
+449
| +56% | +$138K |
|
55
Merck
MRK
$322B
| $347K | 0.03% |
4,451
| – | – |
|
56
Johnson & Johnson
JNJ
$618B
| $340K | 0.03% |
2,161
| – | – |
|
57
Novartis
NVS
$297B
| $334K | 0.02% |
3,535
| – | – |
|
58
Cigna
CI
$73.7B
| $325K | 0.02% |
+1,560
| New | +$306K |
|
59
Sanofi
SNY
$103B
| $323K | 0.02% |
6,650
| – | – |
|
60
Bio-Rad Laboratories Class A
BIO
$8.71B
| $319K | 0.02% |
548
| – | – |
|
61
Pfizer
PFE
$143B
| $312K | 0.02% |
8,469
-457
| -5% | -$16.8K |
|
|
SYNH
62
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $304K | 0.02% |
+4,469
| New | +$279K |
|
63
Envista
NVST
$4.44B
| $303K | 0.02% |
+8,985
| New | +$260K |
|
64
Agilent Technologies
A
$39.1B
| $302K | 0.02% |
2,548
| – | – |
|
65
Gilead Sciences
GILD
$162B
| $301K | 0.02% |
+5,175
| New | +$312K |
|
|
NUVA
66
DELISTED
NuVasive, Inc.
NUVA
| $294K | 0.02% |
+5,228
| New | +$257K |
|
67
CVS Health
CVS
$133B
| $286K | 0.02% |
+4,182
| New | +$272K |
|
68
Baxter International
BAX
$13.5B
| $261K | 0.02% |
3,258
| – | – |
|
69
Amgen
AMGN
$208B
| $251K | 0.02% |
1,092
| – | – |
|
|
HOLX
70
DELISTED
Hologic
HOLX
| $243K | 0.02% |
3,340
| – | – |
|
71
Perrigo
PRGO
$1.4B
| $236K | 0.02% |
+5,275
| New | +$244K |
|
72
ICU Medical
ICUI
$4.21B
| $223K | 0.02% |
+1,041
| New | +$202K |
|
|
HRC
73
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $208K | 0.02% |
+2,121
| New | +$198K |
|
|
GRFS
74
Grifois
GRFS
$5.36B
| $187K | 0.01% |
10,166
| – | – |
|
|
AMRN
75
Amarin Corp
AMRN
$298M
| – | – |
-111,808
| Closed | -$9.41M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, First Light Asset Management held 81 positions worth $1.35B, up 38% from $976M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
First Light Asset Management deployed $77.8M of net new capital in Q4 2020, opening 21 new positions and adding to 33 existing holdings. Its largest new stake was Prothena Corp: 2,056,453 shares worth $24.7M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 72% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was KORU Medical Systems, an estimated $7.76M trimmed.
- First Light Asset Management's largest Q4 2020 buy was Prothena Corp: 2,056,453 shares worth $24.7M.
- First Light Asset Management added most to Health Catalyst in Q4 2020, an estimated $26.6M increase.
- First Light Asset Management's biggest Q4 2020 reduction was KORU Medical Systems, cutting an estimated $7.76M.
- First Light Asset Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $134M.
- First Light Asset Management's ten largest holdings make up 53% of its $1.35B portfolio in Q4 2020.
- First Light Asset Management opened 21 new positions and closed 7 in Q4 2020.
- First Light Asset Management's portfolio value rose 38% quarter-over-quarter to $1.35B.
Based on First Light Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.